Premium
Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?
Author(s) -
Uhl Idun,
Gorynia Inge,
Gallinat Jürgen,
Mulert Christoph,
Wutzler Alexander,
Heinz Andreas,
Juckel Georg
Publication year - 2006
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.803
Subject(s) - serotonergic , citalopram , psychology , reuptake inhibitor , serotonin , placebo , medicine , endocrinology , loudness , saline , audiology , alternative medicine , receptor , pathology
The loudness dependence of auditory evoked potentials (LDAEP) has been discussed as a non‐invasive in vivo marker of central serotonergic function. Evidence for this has been found in animal studies, but studies in humans provide less consistent results. In this study, the relationship between LDAEP and directly modulated central serotonergic activity in healthy subjects was investigated. In a single‐blind cross‐over design, the LDAEP of female participants (age: 24.0 ± 2.3 years) was measured under two conditions: (1) infusion of 20 mg citalopram diluted in 250 ml 0.9% saline and (2) infusion of 250 ml 0.9% saline as placebo. LDAEP was measured at five different time points before, during and up to 60 min after drug/placebo administration and dipole source analysis was performed. The increase of the central serotonin activity in response to citalopram was not accompanied by a significant change of the LDAEP compared to the placebo condition. The result underlines that the acceptance of LDAEP as a marker of central serotonergic function still needs further discussion. Copyright © 2006 John Wiley & Sons, Ltd.